Docetaxel (taxotere, Rhone-Poulenc Rorer).
Docetaxel is the latest in a new class of cytotoxic drug having a specific action on dividing cells. It is potentially a useful, if expensive, treatment for some common cancers in which the response to existing treatments has been generally disappointing.
MacConnachie
A M
AM
D000972:Antineoplastic Agents, Phytogenic / Q000627:therapeutic use*; D000077143:Docetaxel; D016903:Drug Monitoring; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy* / Q000451:nursing; D017239:Paclitaxel / Q000031:analogs & derivatives* / Q000627:therapeutic use; D043823:Taxoids
D000972:Antineoplastic Agents, Phytogenic; D043823:Taxoids; D000077143:Docetaxel; D017239:Paclitaxel